🎓 Lesson 15
D5
Techno-Economic Analysis of Bio-Based Route Switching
Bio-based route switching means choosing the best biological or renewable process path to make a chemical product—like picking between fermentation, enzymatic conversion, or algae-based synthesis—based on both technical performance and economic cost.
🎯 Learning Objectives
- ✓ Calculate minimum selling price (MSP) for two competing bio-based production routes using mass-balanced process models
- ✓ Design a comparative TEA framework to rank three bio-based routes by net present value (NPV) at 20-year horizon
- ✓ Analyze sensitivity of MSP to key variables: feedstock price, enzyme loading, and fermentation titer
- ✓ Explain trade-offs between capital intensity and operational flexibility in consolidated bioprocessing vs. separate hydrolysis and fermentation
📖 Why This Matters
Mining and blasting engineers increasingly interface with integrated biorefineries near mine sites—e.g., using bio-leaching for metal recovery or bio-based explosives precursors (like nitrocellulose from sustainably harvested wood pulp). Understanding how to technically and economically compare bio-routes ensures sustainable feedstock integration without compromising safety, cost, or regulatory compliance. Poor route selection risks stranded capital, supply chain fragility, or unintended environmental burdens—making TEA a critical decision-support tool for green process design.
📘 Core Principles
Bio-based route switching rests on three interlocking domains: (1) Process topology—distinguishing discrete steps (e.g., pretreatment → enzymatic hydrolysis → fermentation → separation) versus consolidated approaches; (2) Techno-economic levers—feedstock composition, conversion efficiency (yield), productivity (g/L/h), downstream recovery energy, and scale-dependent CAPEX/OPEX; (3) Decision criteria—MSP, NPV, internal rate of return (IRR), and GHG intensity per ton of product. TEA bridges biochemical engineering fundamentals (e.g., Monod kinetics, mass/energy balances) with financial engineering (discounted cash flow, depreciation schedules, tax treatment). Route superiority is never absolute—it depends on context: local feedstock availability, policy incentives (e.g., USDA BioPreferred), and co-product valorization potential.
📐 Minimum Selling Price (MSP) Calculation
MSP is the lowest product price required to achieve zero net present value over the project lifetime—i.e., break-even economics. It aggregates all costs (CAPEX amortized, OPEX, taxes) and revenue streams (product + co-products), discounted to present value. Used to benchmark against market prices and assess route viability.
Minimum Selling Price (MSP)
MSP = (Annualized CAPEX + Annual OPEX − Annual Co-product Revenue) / Annual Product OutputBreak-even unit price required for economic viability over project lifetime.
Variables:
| Symbol | Name | Unit | Description |
|---|---|---|---|
| MSP | Minimum Selling Price | USD/ton | Required price per metric ton of main product to achieve zero NPV |
| CAPEX | Total Capital Expenditure | USD | One-time investment for equipment, construction, and commissioning |
| OPEX | Annual Operating Expenditure | USD/yr | Yearly costs including labor, utilities, maintenance, raw materials, and catalysts |
| Co-product Revenue | Annual Revenue from Co-products | USD/yr | Monetized value of secondary outputs (e.g., lignin, animal feed, heat credits) |
| Product Output | Annual Main Product Throughput | ton/yr | Mass of primary product generated annually after purification losses |
Typical Ranges:
Bio-acids (e.g., succinic, glycolic): 480 – 620 USD/ton
Bio-based solvents (e.g., ethyl lactate): 2,100 – 2,900 USD/ton
Bio-ammonia (mine-integrated): 310 – 490 USD/ton
💡 Worked Example
Problem: Compare two routes for bio-based glycolic acid: Route A (fermentation from glucose) and Route B (electro-biocatalytic oxidation of glycerol). For Route A: Total CAPEX = $42M, annual OPEX = $8.3M, plant capacity = 25,000 ton/yr, product yield = 0.65 g/g glucose, discount rate = 8%, project life = 20 yr, no co-products.
1.
Step 1: Calculate annualized CAPEX using capital recovery factor (CRF): CRF = i(1+i)^n / [(1+i)^n − 1] = 0.08(1.08)^20 / [(1.08)^20 − 1] ≈ 0.1019 → Annualized CAPEX = $42M × 0.1019 = $4.28M/yr
2.
Step 2: Total annual cost = Annualized CAPEX + OPEX = $4.28M + $8.3M = $12.58M/yr
3.
Step 3: MSP = Total annual cost / Annual production = $12.58M / 25,000 ton = $503/ton (excluding taxes, working capital, and contingency)
Answer:
The MSP is $503/ton, which falls within the typical range of $480–$620/ton for commercial-scale bio-glycolic acid reported in NREL 2022 techno-economic datasets.
🏗️ Real-World Application
In 2021, Freeport-McMoRan partnered with LanzaTech and the U.S. DOE to evaluate bio-based ammonium nitrate (AN) precursors for blasting agents. Two routes were assessed: (1) Syngas-to-ammonia via gasified forestry residues (indirect biomass route), and (2) Electro-fermentation of CO₂ captured from mine ventilation air into ammonia using engineered microbes. TEA showed Route 2 had 32% lower MSP ($312/ton vs. $458/ton) at 100,000-ton/yr scale due to avoided pretreatment CAPEX and $12/ton carbon credit monetization—but required 2.7× more grid electricity. Site-specific power sourcing (solar+storage) tipped the balance, enabling deployment at Morenci Mine by Q3 2024.